172 related articles for article (PubMed ID: 23877478)
41. A boy with Burkitt lymphoma associated with Noonan syndrome due to a mutation in RAF1.
Cianci P; Tono V; Sala A; Locatelli L; Carta C; Rizzari C; Biondi A; Selicorni A
Am J Med Genet A; 2013 Jun; 161A(6):1401-4. PubMed ID: 23613113
[TBL] [Abstract][Full Text] [Related]
42. [New findings in Noonan syndrome and Leopard syndrome: activating mutations in RAF-1 and SOS-1].
Dereure O
Ann Dermatol Venereol; 2008; 135(8-9):624-5. PubMed ID: 18789305
[No Abstract] [Full Text] [Related]
43. LEOPARD syndrome: a variant of Noonan syndrome strongly associated with hypertrophic cardiomyopathy.
Carcavilla A; Santomé JL; Pinto I; Sánchez-Pozo J; Guillén-Navarro E; Martín-Frías M; Lapunzina P; Ezquieta B
Rev Esp Cardiol (Engl Ed); 2013 May; 66(5):350-6. PubMed ID: 24775816
[TBL] [Abstract][Full Text] [Related]
44. The spectrum of cardiac anomalies in Noonan syndrome as a result of mutations in the PTPN11 gene.
Sznajer Y; Keren B; Baumann C; Pereira S; Alberti C; Elion J; Cavé H; Verloes A
Pediatrics; 2007 Jun; 119(6):e1325-31. PubMed ID: 17515436
[TBL] [Abstract][Full Text] [Related]
45. Neurofibromatosis with fully expressed Noonan syndrome.
Abuelo DN; Meryash DL
Am J Med Genet; 1988 Apr; 29(4):937-41. PubMed ID: 3135755
[TBL] [Abstract][Full Text] [Related]
46. Bilateral giant coronary aneurysms in a 40-year-old male with Noonan syndrome caused by a KRAS germline mutation.
Fujimoto N; Nakajima H; Sugiura E; Dohi K; Kanemitsu S; Yamada N; Aoki Y; Nakatani K; Shimpo H; Nobori T; Ito M
Int J Cardiol; 2014 May; 173(3):e63-6. PubMed ID: 24703799
[No Abstract] [Full Text] [Related]
47. Germline KRAS mutations cause Noonan syndrome.
Schubbert S; Zenker M; Rowe SL; Böll S; Klein C; Bollag G; van der Burgt I; Musante L; Kalscheuer V; Wehner LE; Nguyen H; West B; Zhang KY; Sistermans E; Rauch A; Niemeyer CM; Shannon K; Kratz CP
Nat Genet; 2006 Mar; 38(3):331-6. PubMed ID: 16474405
[TBL] [Abstract][Full Text] [Related]
48. PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) mutations in seven Japanese patients with Noonan syndrome.
Kosaki K; Suzuki T; Muroya K; Hasegawa T; Sato S; Matsuo N; Kosaki R; Nagai T; Hasegawa Y; Ogata T
J Clin Endocrinol Metab; 2002 Aug; 87(8):3529-33. PubMed ID: 12161469
[TBL] [Abstract][Full Text] [Related]
49. Genetics and variation in phenotype in Noonan syndrome.
Jongmans M; Otten B; Noordam K; van der Burgt I
Horm Res; 2004; 62 Suppl 3():56-9. PubMed ID: 15539800
[TBL] [Abstract][Full Text] [Related]
50. Genetic and pathogenetic aspects of Noonan syndrome and related disorders.
Zenker M
Horm Res; 2009 Dec; 72 Suppl 2():57-63. PubMed ID: 20029240
[TBL] [Abstract][Full Text] [Related]
51. Mutation analysis of the genes involved in the Ras-mitogen-activated protein kinase (MAPK) pathway in Korean patients with Noonan syndrome.
Lee ST; Ki CS; Lee HJ
Clin Genet; 2007 Aug; 72(2):150-5. PubMed ID: 17661820
[TBL] [Abstract][Full Text] [Related]
52. Noonan syndrome and moyamoya.
Ganesan V; Kirkham FJ
Pediatr Neurol; 1997 Apr; 16(3):256-8. PubMed ID: 9165521
[TBL] [Abstract][Full Text] [Related]
53. Cardiovascular disease in Noonan syndrome.
Prendiville TW; Gauvreau K; Tworog-Dube E; Patkin L; Kucherlapati RS; Roberts AE; Lacro RV
Arch Dis Child; 2014 Jul; 99(7):629-34. PubMed ID: 24534818
[TBL] [Abstract][Full Text] [Related]
54. Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations.
Zenker M; Lehmann K; Schulz AL; Barth H; Hansmann D; Koenig R; Korinthenberg R; Kreiss-Nachtsheim M; Meinecke P; Morlot S; Mundlos S; Quante AS; Raskin S; Schnabel D; Wehner LE; Kratz CP; Horn D; Kutsche K
J Med Genet; 2007 Feb; 44(2):131-5. PubMed ID: 17056636
[TBL] [Abstract][Full Text] [Related]
55. Double-chambered right ventricle in an adult with Noonan syndrome.
Patel AM; Kim JB; Roberts AE; Aragam J
Cardiol Rev; 2006; 14(5):e16-20. PubMed ID: 16924159
[TBL] [Abstract][Full Text] [Related]
56. Abnormal growth in noonan syndrome: the challenge of optimal therapy.
Savage MO; Padidela R; Kirk JM; Malaquias AC; Jorge AA
Pediatr Endocrinol Rev; 2009 Jun; 6 Suppl 4():523-8. PubMed ID: 19550387
[TBL] [Abstract][Full Text] [Related]
57. [Molecular genetic diagnostics in syndromes associated with the RAS/MAPK signalling pathway].
Molven A; Søvik O; von der Lippe C; Steine SJ; Njølstad PR; Houge G; Prescott TE
Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2358-61. PubMed ID: 19935936
[TBL] [Abstract][Full Text] [Related]
58. Noonan syndrome, the Ras-MAPK signalling pathway and short stature.
Binder G
Horm Res; 2009 Apr; 71 Suppl 2():64-70. PubMed ID: 19407499
[TBL] [Abstract][Full Text] [Related]
59. Spectrum of mutations in Noonan syndrome and their correlation with phenotypes.
Lee BH; Kim JM; Jin HY; Kim GH; Choi JH; Yoo HW
J Pediatr; 2011 Dec; 159(6):1029-35. PubMed ID: 21784453
[TBL] [Abstract][Full Text] [Related]
60. Detailed prenatal and postnatal MRI findings and clinical analysis of RAF1 in Noonan syndrome.
Helenius K; Parkkola R; Arola A; Peltola V; Haanpää MK
Eur J Med Genet; 2022 Nov; 65(11):104626. PubMed ID: 36155125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
